Teladoc | Stigma of Diabetes and Weight Management-Pharmacological Agents for Diabetes & Obesity Infographic

Pharmacological Agents for Diabetes & Obesity Infographic

Pdf Summary

This document is a visual guide to the guidelines for pharmacologic agents in the treatment of diabetes and obesity. The recommendations are based on the American Diabetes Association's Standards of Care in Diabetes for 2023. Incretins and weight management are highlighted as important in the treatment of type 2 diabetes. They can delay the progression from prediabetes to type 2 diabetes, improve glycemia, reduce the need for glucose-lowering medications, and promote sustained diabetes remission. Additionally, they can aid in achieving and maintaining weight loss and reducing obesity-associated health risks.<br /><br />There is strong evidence that obesity management is beneficial for overweight and obese individuals with type 2 diabetes. The document provides treatment options for weight loss, including intensive behavioral counseling, obesity pharmacotherapy, and bariatric surgery. The choice of glucose-lowering medications should consider the patient's weight, and medications for comorbid conditions that lead to weight gain should be minimized.<br /><br />The efficacy of glucose-lowering medications in promoting weight loss varies based on the individual's body mass index (BMI). In certain cases, obesity pharmacotherapy may be considered as an adjunct to nutrition, physical activity, and behavioral counseling. The document also lists specific medications that have shown effectiveness in weight loss in individuals with type 2 diabetes.<br /><br />Overall, the document emphasizes the importance of weight management in the treatment of type 2 diabetes and provides recommendations for pharmacologic interventions. The goal is to improve glycemia, reduce the need for medication, and achieve meaningful weight loss to reduce obesity-associated health risks.

Keywords

pharmacologic agents

diabetes treatment

obesity treatment

American Diabetes Association

Incretins

weight management

type 2 diabetes

glucose-lowering medications

obesity management

weight loss interventions